seung hyun Oh
seung hyun Oh
Verified email at
Cited by
Cited by
Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1α through activation of mitogen-activated protein kinase pathway
YG Yoo, SH Oh, ES Park, H Cho, N Lee, H Park, DK Kim, DY Yu, ...
Journal of Biological Chemistry 278 (40), 39076-39084, 2003
Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis
HY Lee, SH Oh, JK Woo, WY Kim, CS Van Pelt, RE Price, D Cody, H Tran, ...
Journal of the National Cancer Institute 97 (22), 1695-1699, 2005
Regulation of the chondrocyte phenotype by β-catenin
JH Ryu, SJ Kim, SH Kim, CD Oh, SG Hwang, CH Chun, SH Oh, JK Seong, ...
Development 129 (23), 5541-5550, 2002
Structural basis for depletion of heat shock protein 90 client proteins by deguelin
SH Oh, JK Woo, YD Yazici, JN Myers, WY Kim, Q Jin, SS Hong, HJ Park, ...
Journal of the National Cancer Institute 99 (12), 949-961, 2007
Targeting heat shock protein 90 overrides the resistance of lung cancer cells by blocking radiation-induced stabilization of hypoxia-inducible factor-1α
WY Kim, SH Oh, JK Woo, WK Hong, HY Lee
Cancer research 69 (4), 1624-1632, 2009
DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression
MH Cho, JH Park, HJ Choi, MK Park, HY Won, YJ Park, CH Lee, SH Oh, ...
Nature communications 6 (1), 1-14, 2015
Hypoxia-inducible factor 1α and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer
JY Han, SH Oh, F Morgillo, JN Myers, E Kim, WK Hong, HY Lee
Journal of the National Cancer Institute 97 (17), 1272-1286, 2005
Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia‐inducible factor‐1 alpha
SH Oh, JK Woo, Q Jin, HJ Kang, JW Jeong, KW Kim, WK Hong, HY Lee
International journal of cancer 122 (1), 5-14, 2008
Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer
JH Kang, JE Jang, SK Mishra, HJ Lee, CW Nho, D Shin, M Jin, MK Kim, ...
Journal of ethnopharmacology 173, 303-312, 2015
Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway
IH Lee, M Sohn, HJ Lim, S Yoon, H Oh, S Shin, JH Shin, SH Oh, J Kim, ...
Oncogene 33 (38), 4675-4684, 2014
Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis
JW Choi, DG Kim, AE Lee, HR Kim, JY Lee, NH Kwon, YK Shin, ...
PLoS Genet 7 (3), e1001351, 2011
Ginsenoside Rp1 from Panax ginseng exhibits anti-cancer activity by down-regulation of the IGF-1R/Akt pathway in breast cancer cells
JH Kang, KH Song, JK Woo, MH Park, MH Rhee, C Choi, SH Oh
Plant Foods for Human Nutrition 66 (3), 298, 2011
Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells
JH Kang, KH Song, KC Jeong, S Kim, C Choi, CH Lee, SH Oh
BMC cancer 11 (1), 1-13, 2011
Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice
SK Mishra, JH Kang, DK Kim, SH Oh, MK Kim
Journal of ethnopharmacology 143 (2), 524-532, 2012
Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development
WY Kim, Q Jin, SH Oh, ES Kim, YJ Yang, DH Lee, L Feng, C Behrens, ...
Cancer research 69 (18), 7439-7448, 2009
Response of non–small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt-and MAPK kinase 4/C-Jun NH2-terminal kinase pathways: an effective …
HY Lee, SH Oh, YA Suh, JH Baek, V Papadimitrakopoulou, S Huang, ...
Clinical cancer research 11 (16), 6065-6074, 2005
Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1–mediated transcriptional events
JH Kim, DS Choi, OH Lee, SH Oh, SM Lippman, HY Lee
Blood, The Journal of the American Society of Hematology 118 (9), 2622-2631, 2011
Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation
JH Seo, JH Cha, JH Park, CH Jeong, ZY Park, HS Lee, SH Oh, JH Kang, ...
Cancer research 70 (11), 4422-4432, 2010
Insulin-like Growth Factor-I Receptor Signaling Pathway Induces Resistance to the Apoptotic Activities of SCH66336 (Lonafarnib) through Akt/Mammalian Target of Rapamycin …
SH Oh, Q Jin, ES Kim, FR Khuri, HY Lee
Clinical cancer research 14 (5), 1581-1589, 2008
A novel topoisomerase inhibitor, daurinol, suppresses growth of HCT116 cells with low hematological toxicity compared to etoposide
K Kang, SH Oh, JH Yun, EH Jho, JH Kang, D Batsuren, J Tunsag, ...
Neoplasia 13 (11), 1043-IN30, 2011
The system can't perform the operation now. Try again later.
Articles 1–20